Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Antal

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Oncotarget|August 28, 2016
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcomaMarta Hegyi, Adam Arany, Agnes F Semsei, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Plos One|March 10, 2015
Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressorsGabriella Juhasz, Xenia Gonda, Gabor Hullam, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2023
Partial Thermal Condensation Mediated Synthesis of High-Density Nickel Single Atom Sites on Carbon Nitride for Selective Photooxidation of Methane into MethanolPawan Kumar, Peter Antal, Xiyang Wang, et al.
Journal of Hepatology|May 4, 2013
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosisMaria Papp, Nora Sipeki, Zsuzsanna Vitalis, et al.
Journal of Medical Internet Research|June 24, 2024
Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation StudyRubèn González-Colom, Kangkana Mitra, Emili Vela, et al.
Scientific Reports|January 12, 2018
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitisTamas Tornai, David Tornai, Nora Sipeki, et al.
World Journal of Gastroenterology|August 26, 2017
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitisTamas Tornai, Eszter Palyu, Zsuzsanna Vitalis, et al.
Progress in Neurobiology|August 31, 2025
Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future researchPasindu Hansana Singhaarachchi, Peter Antal, Frédéric Calon, et al.
Neuroscience and Biobehavioral Reviews|May 18, 2024
Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease researchPasindu Hansana Singhaarachchi, Peter Antal, Frédéric Calon, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Oncotarget|August 28, 2016
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcomaMarta Hegyi, Adam Arany, Agnes F Semsei, et al.
Scientific Reports|March 27, 2023
Genetic risk of depression is different in subgroups of dietary ratio of tryptophan to large neutral amino acidsBence Bruncsics, Gabor Hullam, Bence Bolgar, et al.
Plos One|March 10, 2015
Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressorsGabriella Juhasz, Xenia Gonda, Gabor Hullam, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2023
Partial Thermal Condensation Mediated Synthesis of High-Density Nickel Single Atom Sites on Carbon Nitride for Selective Photooxidation of Methane into MethanolPawan Kumar, Peter Antal, Xiyang Wang, et al.
Journal of Hepatology|May 4, 2013
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosisMaria Papp, Nora Sipeki, Zsuzsanna Vitalis, et al.
Journal of Medical Internet Research|June 24, 2024
Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation StudyRubèn González-Colom, Kangkana Mitra, Emili Vela, et al.
Scientific Reports|January 12, 2018
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitisTamas Tornai, David Tornai, Nora Sipeki, et al.
World Journal of Gastroenterology|August 26, 2017
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitisTamas Tornai, Eszter Palyu, Zsuzsanna Vitalis, et al.
Progress in Neurobiology|August 31, 2025
Rodent models of Alzheimer's disease: Critical analysis of current hypotheses and pathways for future researchPasindu Hansana Singhaarachchi, Peter Antal, Frédéric Calon, et al.
Neuroscience and Biobehavioral Reviews|May 18, 2024
Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease researchPasindu Hansana Singhaarachchi, Peter Antal, Frédéric Calon, et al.
Pageof 7